article thumbnail

FDA Solicits Feedback on the Use of AI and Machine Learning in Drug Development

Bill of Health

Food and Drug Administration (FDA), in fulfilling its task of ensuring that drugs are safe and effective, has recently turned its attention to the growing use of artificial intelligence (AI) and machine learning (ML) in drug development. By Matthew Chun The U.S. manufacturing process design), implement advanced process controls (e.g.,

FDA 264
article thumbnail

VR roundup: FDA clears new device for pain, Stanford says immersive therapeutics can help seniors

Healthcare It News

Previously, on September 25, FDA cleared the VR system for the drug-free, temporary relief of acute anxiety associated with needle procedures, Smileyscope said. The company holds a patent for Procedural Choreography, a proprietary technique that reframes real-world stimuli with positive virtual stimuli.

FDA 268
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. My talk was titled “Legal Approaches to Ensuring Timely Generic Drug Availability.”

article thumbnail

FDA Cybersecurity Requirements for Medical Devices Now in Effect

HIPAA Journal

Food and Drug Administration (FDA) will not authorize their use. trillion omnibus spending bill – The Consolidated Appropriations Act, 2023 – took effect and the FDA now requires all regulatory submissions for medical devices to include information about the cybersecurity measures that have been implemented for the devices.

FDA 115
article thumbnail

Senate Committee Told How Federal Government Can Improve Healthcare Cybersecurity

HIPAA Journal

Senate Committee on Homeland Security and Governmental Affairs held a hearing to examine cybersecurity risks to the healthcare sector, how healthcare providers and the federal government are working to combat those threats, and determine what the federal government needs to do to improve defenses against cyberattacks on the healthcare sector.

article thumbnail

Book Review: ‘The Truth Pill: The Myth of Drug Regulation in India’

Bill of Health

In fact, before publishing the book, the authors petitioned the government, highlighting glaring regulatory issues, but the government turned a blind eye. The book relies on primary sources of information — mainly government reports, judicial decisions, and government data.

article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

On top of that comprehensive rulebook, the European Data Strategy bundle of laws encompasses the EU General Data Protection Regulation (GDPR), the Free Flow of Non-Personal Data Regulation, the Data Governance Act and the Data Act, as part of the EC’s ambition to establish a single unified market for data. The sectorialism of the U.S.

FDA 288